Iovance Biotherapeutics Inc (IOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IOVA | FTRE | XENE | ||
| Company | Iovance Biotherapeutics Inc | Fortrea Holdings Inc | Xenon Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 11.60 | 36.27 | 40.02 | ||
| High | 11.80 | 37.07 | 40.87 | ||
| Low | 11.34 | 36.13 | 40.02 | ||
| Last | 11.64 | 36.35 | 40.50 | ||
| Change | +0.10 | unch | +0.40 | ||
| % Change | +0.87% | unch | +1.00% | ||
| Volume | 2,477,439 | 413,403 | 317,101 | ||
| 20-Day Average Volume | 4,167,437 | 772,350 | 315,705 | ||
| Previous Close | 11.54 | 36.35 | 40.10 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 12.51 | 37.87 | 41.38 | ||
| 20-Day Raw Stochastic | 16.76% | 22.18% | 37.08% | ||
| 20-Day Relative Strength | 42.70% | 45.56% | 41.69% | ||
| Weighted Alpha | +27.92 | +23.79 | -4.64 | ||
| Today's Opinion | 40% Buy | 56% Buy | 8% Sell | ||
| Previous Opinion | 40% Buy | 56% Buy | 8% Sell | ||
| Last Month's Opinion | 88% Buy | 72% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.92% since 04/19/24 | +2.39% since 04/19/24 | +1.55% since 04/19/24 | ||
| Low | 11.07 on 04/22/24 | 35.13 on 04/22/24 | 38.85 on 04/25/24 | ||
| High | 12.14 on 04/24/24 | 37.93 on 04/24/24 | 41.59 on 04/23/24 | ||
| 1-Month | |||||
| %Chg | -17.15% since 03/26/24 | -6.44% since 03/26/24 | -5.06% since 03/26/24 | ||
| Low | 11.01 on 04/19/24 | 35.13 on 04/22/24 | 38.85 on 04/25/24 | ||
| High | 15.18 on 03/28/24 | 40.63 on 04/01/24 | 43.54 on 03/28/24 | ||
| 3-Month | |||||
| %Chg | +53.36% since 01/26/24 | +17.56% since 01/26/24 | -11.26% since 01/26/24 | ||
| Low | 7.34 on 01/29/24 | 30.16 on 02/05/24 | 38.85 on 04/25/24 | ||
| High | 18.33 on 02/28/24 | 41.02 on 03/21/24 | 50.99 on 03/01/24 | ||
| 6-Month | |||||
| %Chg | +214.59% since 10/26/23 | +30.29% since 10/26/23 | +30.06% since 10/26/23 | ||
| Low | 3.47 on 10/27/23 | 26.85 on 10/30/23 | 27.99 on 11/13/23 | ||
| High | 18.33 on 02/28/24 | 41.02 on 03/21/24 | 50.99 on 03/01/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,223,203 | 3,248,745 | 3,024,823 | ||
| Shares Outstanding, K | 279,307 | 89,374 | 75,432 | ||
| Annual Sales | 1,190,000 | 3,109,000,000 | 0 | ||
| Annual Net Income | -444,040,000 | -3,400,000 | -182,390,000 | ||
| Last Quarter Sales | 480,000 | 775,400,000 | 0 | ||
| Last Quarter Net Income | -116,380,000 | -36,000,000 | -44,740,000 | ||
| 60-Month Beta | 0.62 | N/A | 1.15 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.45 on 02/28/24 | 0.19 on 03/11/24 | -0.64 on 02/29/24 | ||
| Latest Earnings Date | 05/14/24 | 05/07/24 | 05/14/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||